BIOSECURE Act of 2025 prohibits U.S. agencies from contracting with biotechnology companies posing national security risks.
The BIOSECURE Act of 2025 aims to protect national security by prohibiting U.S. executive agencies from procuring biotechnology equipment or services from companies deemed to pose risks. These companies, termed "biotechnology companies of concern," are identified based on their involvement in biotechnology, control by foreign adversaries, or risk to U.S. national security. The Act mandates the Director of the Office of Management and Budget to publish a list of these companies, with input from various federal agencies, and requires annual reporting on intelligence related to these companies.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.